This week, Jeremy welcomes Melanie Lendnal, The ALS Association’s vice president of policy and advocacy, to learn how advocacy can be deployed to make sure insurers provide access to approved treatments.

Learn more about the letters to insurers at https://www.als.org/stories-news/als-association-fights-access-relyrvio

For more information on the VA’s decision to approve access to Relyvrio go to https://www.als.org/stories-news/va-approves-access-relyvrio-veterans-living-als

Explore the drug coverage decision making process at https://share.transistor.fm/s/67de0365

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.